20.46
6.75%
-1.48
After Hours:
20.46
Phreesia Inc stock is currently priced at $20.46, with a 24-hour trading volume of 591.30K.
It has seen a -6.75% decreased in the last 24 hours and a -11.08% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $22.24 pivot point. If it approaches the $19.87 support level, significant changes may occur.
Previous Close:
$21.94
Open:
$21.44
24h Volume:
591.30K
Market Cap:
$1.15B
Revenue:
$356.30M
Net Income/Loss:
$-136.89M
P/E Ratio:
-7.1538
EPS:
-2.86
Net Cash Flow:
$-57.48M
1W Performance:
-9.55%
1M Performance:
-11.08%
6M Performance:
+53.37%
1Y Performance:
-37.62%
Phreesia Inc Stock (PHR) Company Profile
Name
Phreesia Inc
Sector
Industry
Phone
888-654-7473
Address
432 Park Avenue South, 12th Floor Between 29th & 30th Streets, New York
Phreesia Inc Stock (PHR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-26-24 | Initiated | Truist | Buy |
Jan-17-24 | Upgrade | DA Davidson | Neutral → Buy |
Jan-03-24 | Initiated | Barclays | Overweight |
Apr-12-23 | Initiated | Stephens | Overweight |
Jan-04-23 | Reiterated | Needham | Buy |
Dec-13-22 | Upgrade | Citigroup | Neutral → Buy |
Dec-09-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Oct-13-22 | Initiated | DA Davidson | Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
Apr-14-22 | Initiated | Guggenheim | Buy |
Jan-06-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Dec-02-21 | Initiated | Jefferies | Buy |
Sep-02-21 | Reiterated | Needham | Buy |
Aug-27-21 | Initiated | Canaccord Genuity | Buy |
Jul-13-21 | Initiated | JMP Securities | Mkt Outperform |
Jun-08-21 | Initiated | Berenberg | Buy |
Apr-29-21 | Resumed | JP Morgan | Overweight |
Apr-01-21 | Initiated | Robert W. Baird | Outperform |
Nov-11-20 | Initiated | Stephens | Overweight |
Oct-27-20 | Initiated | Needham | Buy |
Sep-22-20 | Initiated | DA Davidson | Buy |
Jul-14-20 | Initiated | Citigroup | Neutral |
May-15-20 | Initiated | Guggenheim | Buy |
Apr-21-20 | Initiated | RBC Capital Mkts | Sector Perform |
Apr-13-20 | Initiated | SVB Leerink | Outperform |
Jan-31-20 | Initiated | KeyBanc Capital Markets | Overweight |
Jan-09-20 | Initiated | Cantor Fitzgerald | Overweight |
Dec-20-19 | Initiated | Raymond James | Outperform |
Oct-11-19 | Initiated | Robert W. Baird | Outperform |
Aug-13-19 | Initiated | JP Morgan | Overweight |
Aug-12-19 | Initiated | Piper Jaffray | Overweight |
Aug-12-19 | Initiated | Wells Fargo | Outperform |
Aug-12-19 | Initiated | William Blair | Outperform |
Jul-23-19 | Initiated | Chardan Capital Markets | Buy |
View All
Phreesia Inc Stock (PHR) Latest News
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks Investment Research
Stock Market News for Mar 18, 2024
Zacks Investment Research
Analyst Expectations For Phreesia's Future
Benzinga
Phreesia (PHR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research
Phreesia (PHR) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
Will Phreesia (PHR) Report Negative Earnings Next Week? What You Should Know
Zacks Investment Research
Phreesia Inc Stock (PHR) Financials Data
Phreesia Inc (PHR) Revenue 2024
PHR reported a revenue (TTM) of $356.30 million for the quarter ending January 31, 2024, a +26.84% rise year-over-year.
Phreesia Inc (PHR) Net Income 2024
PHR net income (TTM) was -$136.88 million for the quarter ending January 31, 2024, a +22.29% increase year-over-year.
Phreesia Inc (PHR) Cash Flow 2024
PHR recorded a free cash flow (TTM) of -$57.48 million for the quarter ending January 31, 2024, a +50.59% increase year-over-year.
Phreesia Inc (PHR) Earnings per Share 2024
PHR earnings per share (TTM) was -$2.51 for the quarter ending January 31, 2024, a +25.30% growth year-over-year.
About Phreesia Inc
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments. It deploys its platform in a range of modalities, including through Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Stations that are on-site kiosks. The company's Phreesia Platform provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; clinical support solution that collects clinical intake and PRO data for approximately 25 specialties; appointments solution for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. It serves patients, healthcare provider organizations, and life sciences companies. The company was founded in 2005 and is headquartered in New York, New York.
Cap:
|
Volume (24h):